6:12 PM
 | 
May 04, 2009
 |  BC Extra  |  Company News

Acadia jumps on pimavanserin deal

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) rose $1.34 (134%) to $2.34 on 2.9 million shares on Monday after granting Biovail Corp. (TSX:BVF; NYSE:BVF) exclusive rights in...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >